Champions Oncology Inc. Registered Shares DL -,01
- BID
5.3
- ASK
5.4
- 1,301 Units1,272 Units
- 07/21, 11:29:58 AM
Sector and Industry
Healthcare, Healthcare Services
Performance (1Y)
18.94%
Market Cap
-
P/E Ratio
0.00
Dividend Yield
0.00 %
Earnings per Share
0.00 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| UnitedHealth Group Inc. | 254.66 Bil. | 396.73 Bil. | 24.94 | -19.75 % | 0.00 | - |
| Thermo Fisher Scientific Inc. | 185.62 Bil. | 39.50 Bil. | 32.67 | +1.45 % | 0.00 | - |
| Danaher Corp. | 137.79 Bil. | 21.78 Bil. | 45.36 | -11.47 % | 0.00 | - |
| McKesson Corporation | 90.13 Bil. | 348.09 Bil. | 22.55 | +33.83 % | 0.00 | - |
| HCA Healthcare Inc. | 89.28 Bil. | 67.01 Bil. | 16.48 | +12.93 % | 0.00 | - |
| Elevance Health Inc. | 65.88 Bil. | 176.51 Bil. | 13.91 | -9.22 % | 0.00 | - |
| The Cigna Group | 61.74 Bil. | 243.65 Bil. | 12.41 | +66.33 % | 0.00 | - |
| Cencora Inc. | 51.58 Bil. | 291.15 Bil. | 39.26 | +1.16 % | 0.00 | - |
| IDEXX Laboratories Inc. | 45.92 Bil. | 3.81 Bil. | 51.74 | +14.41 % | 0.00 | - |
| Zoetis Inc. | 45.52 Bil. | 8.39 Bil. | 20.89 | +3.10 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 5.3 G | 0 Units |
| PRICE DETERMINATION TIME | 07/21/2026 / 11:17:06 AM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 5.3 | 5.3 |
| PREV. DAY'S PRICE | 5.35 | (07/20) |
| CHANGE DAY BEFORE | -0.05 | -0.93 % |
| 52 WEEK HIGH / LOW | 6.65 (07/21) | 4.66 (07/06) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026 | 2027 | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | -0.50 | 0.31 | - | - | - |
DIVIDENDS PER SHARE | 0.00 | 0.00 | - | - | - |
DIVIDEND YIELD IN % | 0.00 % | 0.00 % | - | - | - |
DIVIDEND GROWTH IN % | - | - | - | - | - |
PRICE - EARNINGS RATIO | - | 21.70 | - | - | - |
PRICE - BOOK RATIO | - | 26.11 | - | - | - |
PRICE - SALES RATIO | 1.31 | 1.79 | - | - | - |
PRICE - CASH FLOW RATIO | - | 13.81 | - | - | - |
Master Data
| WKN | A14X6S |
| ISIN | US15870P3073 |
| SYMBOL | 2I3 |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | CHAMPIONS ONCOLOGY DL-,01 |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | - |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Healthcare Services |
| NUMBER OF SHARES | - |
| MARKET CAPITALISATION | - |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | 7.00 % | -0.93 % | 5.94 % | -6.14 % | -18.94 % | -7.76 % | -34.36 % | -0.93 % |
| HIGH | 5.35 | 5.80 | 5.90 | 6.35 | 6.65 | 10.60 | 10.60 | 6.35 |
| LOW | 4.80 | 4.66 | 4.66 | 4.66 | 4.66 | 3.22 | 3.22 | 4.66 |
Dividende
pro Aktie
CHAMPIONS ONCOLOGY DL-,01 does not deliver dividend information
Company profile
Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. Its technology platform, TumorGraft, is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company was founded by James M. Martell and David Sidransky on June 4, 1985 and is headquartered in Hackensack, NJ.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.